Every cycle includes the complete peptide supply, bacteriostatic water, syringes, alcohol swabs, a sharps container, step-by-step instructional videos, a dosing calendar, written protocol guides, provider access during the cycle, and body composition analysis at follow-up visits
DSIP should not replace conventional medical treatment for serious sleep disorders, sleep apnea, or underlying medical conditions affecting sleep
It is unclear where DSIP is synthesized
Tirzepatide's dual receptor mechanism How tirzepatide works: Dual GIP/GLP-1 receptor agonist Single molecule, two pathways GIP (glucose-dependent insulinotropic polypeptide) + GLP-1 Weekly subcutaneous injection FDA approved for diabetes and obesity GIP pathway effects: Enhances insulin secretion Improves insulin sensitivity Promotes fat metabolism Reduces inflammation Works synergistically with GLP-1 GLP-1 pathway effects: Suppresses appetite (central brain effects) Slows gastric emptying (moderate) Increases satiety Reduces glucagon Improves glucose control Combined tirzepatide results: 15-22% average body weight loss (monotherapy) Superior to semaglutide (GLP-1 alone) Well-tolerated in trials Approved and available See our tirzepatide dosing guide , semaglutide vs tirzepatide , and peptides for weight loss at SeekPeptides